New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2

Farmaco. 2005 Mar;60(3):185-202. doi: 10.1016/j.farmac.2004.09.007.

Abstract

Extracellular adenosine and adenine nucleotides induce various cellular responses through activation of P1 and P2 receptors. P1 receptors preferentially recognize adenosine and four different G protein-coupled receptors (A(1), A(2A), A(2B), and A(3) subtypes) have been identified. On the other hand, P2 receptors are activated by adenine and/or uridine nucleotides and classified into two families: ionotropic P2X and G protein-coupled P2Y receptors. In this article, we summarize our studies which led to development of new potent and selective heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2X(7).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine Nucleotides / chemical synthesis*
  • Adenine Nucleotides / metabolism
  • Adenine Nucleotides / pharmacology
  • Adenosine Triphosphate / metabolism*
  • Animals
  • Cell Membrane / metabolism
  • Cells, Cultured
  • Enzyme Activation / drug effects
  • Extracellular Space / metabolism
  • Humans
  • Ligands
  • Receptors, G-Protein-Coupled / metabolism
  • Receptors, Purinergic P1 / drug effects*
  • Receptors, Purinergic P1 / metabolism
  • Receptors, Purinergic P2 / drug effects*
  • Receptors, Purinergic P2 / metabolism
  • Structure-Activity Relationship

Substances

  • Adenine Nucleotides
  • Ligands
  • Receptors, G-Protein-Coupled
  • Receptors, Purinergic P1
  • Receptors, Purinergic P2
  • Adenosine Triphosphate